Scarica l'app Stockscreener
0.52
1.53%
-0.0081
Dopo l'orario di chiusura:
.52
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché MBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.5281
Aprire:
$0.5398
Volume 24 ore:
20,623
Relative Volume:
0.52
Capitalizzazione di mercato:
$3.94M
Reddito:
-
Utile/perdita netta:
$-2.72M
Rapporto P/E:
-1.0831
EPS:
-0.4801
Flusso di cassa netto:
$-4.88M
1 W Prestazione:
-7.14%
1M Prestazione:
-11.88%
6M Prestazione:
-47.47%
1 anno Prestazione:
-63.12%
Intervallo 1D:
$0.52
$0.5398
Intervallo di 1 settimana:
$0.52
$0.5582
Portata 52W:
$0.52
$1.85
Mustang Bio Inc Stock (MBIO) Company Profile
Nome
Mustang Bio Inc
Settore
Industria
Telefono
(781) 652-4500
Indirizzo
95 SAWYER RD, WALTHAM, NY
Compare MBIO vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBIO
Mustang Bio Inc
|
0.52 | 4.00M | 0 | -2.72M | -4.88M | -0.4801 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mustang Bio Inc Stock (MBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-18 | Iniziato | BTIG Research | Buy |
| 2020-10-02 | Iniziato | B. Riley FBR | Buy |
| 2019-11-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-08-13 | Iniziato | H.C. Wainwright | Buy |
| 2019-06-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-12-21 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Mustang Bio Inc Borsa (MBIO) Ultime notizie
Mustang Bio Stock Price Forecast. Should You Buy MBIO? - StockInvest.us
Mustang Bio Inc. (MBIO) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Mustang Bio Inc. (MBIO) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com
Mustang (MBIO) EPS and Revenue: EPS Misses Its Estimate in the Latest Session; Market Response: The Market Price Moves 0.70% Higher in the Latest ReadingManagement Tone Analysis - vinanet.vn
Pediatrix (MD) Trading-Day Recap: Ends Higher by 0.84% at $26.56 on the Day; Level Position: Support at $25.23 and Resistance at $27.89 Frame the RangeReversal Trade - vinanet.vn
FSBC Q2 2026 Earnings: EPS Surpasses Estimates Despite Share DipCapex Guidance - vinanet.vn
BHE Q2 2026 Earnings: EPS Beats Estimates by 8.4% as Bottom-Line Strength Drives Shares HigherROIC Trend Report - Vinanet
Mustang Bio (MBIO) Edges Higher by 3% as Shares Test Key Resistance at $0.64Dark Pool Prints - Vinanet
Mustang Bio Inc. (MBIO) Holds Steady at $0.60 as Narrow Trading Range PersistsPre-Earnings Momentum - dars.gov.et
Mustang Bio Inc (MBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Segment Evaluation and Major Growth Areas in the Viral Vector Production (Research-Use) Market - openPR.com
Leading Companies Consolidating Their Presence in the Viral Vector Manufacturing Market - openPR.com
Mustang Bio Q2 net loss widens 41% to $1.07 million - Bitget
MUSTANG BIO, INC. Q2 2026: Net income $(1.07)M, EPS $(0.16) — 10-Q Summary - TradingView
MBIO: Net loss widened, cash reserves declined, and Nasdaq delisting risk remains amid ongoing R&D focus - TradingView
Mustang Bio, Inc. (NASDAQ: MBIO) posts $2.0M loss and faces Nasdaq bid-price warning - Stock Titan
Mustang Bio (MBIO) Holds $0.58 Support Zone as Gene Therapy Stock Ticks HigherPCR Moving Average - dars.gov.et
Fortress Biotech Just Netted $159 MillionIts Preferred Shares Could Be The Real Winner - Seeking Alpha
Glioblastoma Pipeline 2026: FDA Approvals, Therapies, - openPR.com
Mustang Bio Inc (MBIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mustang Bio, Inc. Revenue Breakdown – NASDAQ:MBIO - TradingView
Mustang Bio Inc (MBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mustang Bio Inc (MBIO) Cash Flow - TradingKey
MBIO|Mustang Bio Inc|Price:0.560|Chg%:-0.002 - TradingKey
TradingKey - TradingKey
Sezzle (SEZL) Drops 3.22% as Shares Approach Key Support Near $146Intraday Profile - vinanet.vn
Europe Gene Therapy Market Size, Growth & Forecast, 2034 - Market Data Forecast
Frontier tech research, news & data - MLQ.ai
Mustang Containment Solutions Acquires Mustang Extreme's Western and Southwestern Environmental Lining and Water Management Assets - Yahoo Finance
MBIO Q4 2024 Earnings: Significant EPS Miss Amid Pre-Revenue Biotech OperationsCore Business Growth - vinanet.vn
Car T Cell Therapy Market Set to Booming Growth 2026-2033 | Novartis AG, Gilead Sciences, Inc - EIN News
Coca-Cola (KO) Edges Higher as Defensive Appeal Draws Investor InterestMax Pain Level - vinanet.vn
Mustang Bio stock trades lower as cash runway and trial update shape outlook - Ad-hoc-news.de
Mesa Royalty Trust (MTR) Declines 2.2% as Stock Nears Critical Support at $2.95Shakeout Pattern - po-news-eg.net
MSN Money - MSN
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Significant EPS Miss Amidst Ongoing Operational Challenges - vinanet.vn
Americore Resources Appoints Justin Hanka to Its Board of Directors - Moomoo
MBIO Q4 2024 Earnings: EPS Misses Estimates by Wide Margin Amid Operational ChallengesDiluted EPS Report - vinanet.vn
AstraZeneca’s Clinical Setback Casts Doubt on Premium Valuation Amid Pipeline ConcernsMargin Expansion Trends - po-news-eg.net
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Deep Losses Overshadow Progress in CAR T PipelineGuidance Update - DonanımHaber
Mustang Bio (MBIO) Q1 2026 earnings summary - Quartr
Mustang Bio (MBIO) Proxy Filing Summary - Quartr
Mustang Bio (MBIO) Registration Filing Summary - Quartr
Mustang Bio Inc. (MBIO) Q4 2024 Earnings: Significant EPS Miss Reflects Operational ChallengesStrong Earnings Momentum - po-news-eg.net
TDW Q1 2026 Earnings: Significant EPS Miss Despite Stock GainDebt Analysis Report - dars.gov.et
MBIO Should I Buy - Intellectia AI
MBIO Q4 2024 Earnings: Massive EPS Miss as Clinical-Stage Biotech Reports No RevenueEarnings Revision Report - dars.gov.et
MBIO Q4 2024 Earnings: Significant EPS Miss as Pre-Revenue Biotech Continues DevelopmentFinancial Summary - dars.gov.et
Enterprise value to EBIT forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Enterprise value to EBITDA forward of Mustang Bio, Inc. – NASDAQ:MBIO - TradingView
Enterprise value to EBIT forward of Mustang Bio, Inc. – BOATS:MBIO - TradingView
Mustang Bio Inc Azioni (MBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):